115 results
Page 5 of 6
6-K
EX-99
0foym9rxrvk37adv
16 Dec 14
Current report (foreign)
12:00am
424B2
lr03jwga5gcin08wyha
13 Jun 14
Prospectus for primary offering
12:00am
F-3
y4ieoc9
30 May 14
Shelf registration (foreign)
12:00am
424B5
uzuzyp o6obi9qapshn
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
t8tyw
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
qkqh8swykr2 pxk
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
9t7fhpb 7rn9
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
11ywtevlb0b65
8 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
nnsjb2m
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
424B3
54qfm2r1h7x89obvzru
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
0veirdewfocq3
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
tika526yd4avdjy54ii
10 Jul 13
2013 Annual General Meeting of Shareholders
12:00am
6-K
EX-99
i8g 8rm0ji60bmm
28 Feb 13
Current report (foreign)
12:00am
424B5
liaazmgn84t ngc67se7
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
4k233r veg
15 Oct 12
Prospectus supplement
12:00am
F-1
hzm5mdvfcab6
2 Oct 12
Registration statement (foreign)
12:00am
POS AM
d3o8p 2ymm6p
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
rrd7vsjj
23 Jul 12
Shelf registration (foreign) (amended)
12:00am